These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8641042)

  • 1. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 3. Nifedipine study.
    Lichtlen PR
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641040
    [No Abstract]   [Full Text] [Related]  

  • 4. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

  • 6. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calcium antagonists: safe or unsafe?].
    Rosendaal FR; Psaty BM; Furberg CD
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):916-8. PubMed ID: 8676969
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New nifedipine preparation makes single daily dose possible].
    Fortschr Med; 1997 Nov; 115(33):following 54. PubMed ID: 9480274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Korinfar in the treatment of patients with arterial hypertension].
    Lautsevichus LZ; Kibarskis KhKh; Razukas VA; Nauiokaĭtene RS
    Vrach Delo; 1986 Sep; (9):26-8. PubMed ID: 3788106
    [No Abstract]   [Full Text] [Related]  

  • 12. [A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?].
    Wenzel UO; Pfalzer B; Meinertz T; Stahl RA
    Internist (Berl); 1999 Feb; 40(2):205-9. PubMed ID: 10097979
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 15. The calcium channel antagonist controversy.
    Gavras I; Gavras H
    Am Fam Physician; 1998 Apr; 57(7):1484, 1492. PubMed ID: 9556636
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the safety of short-acting nifedipine in children with hypertension.
    Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S
    Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of sublingual nifedipine: a continuing concern.
    Messerli FH; Grossman E
    Arch Intern Med; 1999 Oct; 159(19):2259-60. PubMed ID: 10547164
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hemodynamic effects of lomir and adalat in patients with postoperative arterial hypertension].
    Eremenko AA; Ziuliaeva TP; Bozh'eva LV; Borisov RIu
    Anesteziol Reanimatol; 1999; (5):63-6. PubMed ID: 10560156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced gingival hyperplasia].
    Nohl F; Ferrari P
    Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.